YOLFTbeta
Valbiotis SAS

Valbiotis SAS

ALVAL · PA · Consumer Defensive / Packaged Foods

0.60EUR-0.02 (-2.60%)

Price History

Full chart

Market Stats

Previous Close0.616
Open0.619
Day Range0.60 – 0.628
52-Week Range0.5261 – 1.27
Volume102.48K
Market Cap22.61M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.46
Dividend Yield0.00%
Beta-0.20
50-Day Avg0.7813
200-Day Avg0.8989

About

Valbiotis SA engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France and Asia. The company offers supplements for immunity and vitality, health and wellbeing, metabolic and cardiovascular health, and beauty and physical comfort. It also develops TOTUM-63 for the reduction of fasting blood glucose and treatment of type 2 diabetes; TOTUM-854, which is in Phase II/III clinical trials for reducing systolic blood pressure; and TOTUM-448 for the reduction of hepatic steatosis. Additionally, the company offers e-commerce delivery service in Belgium and Luxembourg. Valbiotis SA was incorporated in 2014 and is based in Périgny, France.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Sebastien Peltier HDR, Ph.D.
  • Employees50
  • HeadquartersRue Paul Vatine, Périgny, France, 17180, France
  • Websitehttps://www.valbiotis.com

Leadership

  • Mr. Sebastien Peltier HDR, Ph.D.Co-Founder, Chairman of the Management Board & CEO · b. 1978
  • Mr. Stanislas SordetCFO & Member of Management Board
  • Mr. Sebastien BessyCOO & Member of the Management Board
  • Mr. Pascal Sirvent Ph.D.CSO & Member of the Management Board
  • Ms. Murielle CazaubielCMO & Member of the Management Board
  • Mr. Sebastien PoncetMember of the Management Board
  • Dr. Josep InfestaHead of Global Business Development

Financials

Income Statement

Currency: EUR2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue10.00K646.00K3.00K79.00K91.00K3.09M298.00K785.00K4.73M175.00K905.00K
Growth (%)-+6360.00%-99.54%+2533.33%+15.19%+3297.80%-90.36%+163.42%+502.93%-96.30%+417.14%
Cost of Revenue38.00K26.00K69.00K398.00K17.00K4.00K16.00K18.00K2.04M2.62M2.07M
Gross Profit-28.00K620.00K-66.00K-319.00K74.00K3.09M282.00K767.00K2.69M-2.44M-1.17M
Gross Margin-280.00%95.98%-2200.00%-403.80%81.32%99.87%94.63%97.71%56.81%-1396.00%-128.84%
Operating Expense927.00K1.19M2.33M4.47M7.05M8.50M11.15M14.82M9.85M7.98M8.33M
Operating Income-955.00K-572.00K-2.40M-4.79M-6.98M-5.41M-10.87M-14.05M-7.16M-10.42M-9.49M
Operating Margin-9550.00%-88.54%-80033.33%-6060.76%-7669.23%-175.10%-3647.99%-1790.45%-151.28%-5956.00%-1049.06%
EBITDA-908.00K-882.00K-2.33M-4.53M-4.22M-2.37M-9.14M-11.13M-6.41M-9.17M-9.28M
EBITDA Margin-9080.00%-136.53%-77733.33%-5735.44%-4637.36%-76.65%-3067.79%-1418.34%-135.45%-5241.14%-1025.30%
Net Income-739.00K-593.00K-2.44M-4.97M-5.50M-3.83M-8.68M-12.31M-7.37M-10.03M-9.42M
Net Income Margin-7390.00%-91.80%-81433.33%-6287.34%-6048.35%-123.84%-2913.09%-1568.41%-155.67%-5728.57%-1040.55%
R&D705.00K788.00K1.65M3.83M3.20M4.54M7.03M9.10M7.15M4.33M921.00K
R&D as % of Total Revenue7050.00%121.98%55100.00%4843.04%3518.68%146.70%2358.39%1159.49%151.07%2475.43%101.77%
Interest Expense20.00K23.00K76.00K83.00K358.00K421.00K348.00K287.00K221.00K230.00K161.00K
Interest Expense % of Total Revenue200.00%3.56%2533.33%105.06%393.41%13.62%116.78%36.56%4.67%131.43%17.79%

Balance Sheet

Currency: EUR2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.16M1.62M12.71M11.91M15.02M21.00M28.48M27.17M33.31M19.61M14.39M
Total Liabilities1.08M1.25M2.55M4.50M6.81M13.93M14.25M13.86M13.71M9.24M7.43M
Total Equity79.00K368.00K10.16M7.41M8.21M7.15M14.23M13.31M19.60M10.37M6.96M
Cash592.00K529.00K10.60M7.42M8.03M14.59M21.82M20.83M25.02M11.58M8.68M
Total Debt761.00K806.00K1.69M2.80M4.78M7.01M7.59M7.18M6.88M5.72M5.09M
Net Debt169.00K277.00K-8.91M-4.62M-3.26M-7.57M-14.23M-13.65M-18.14M-5.86M-3.59M

Cash Flow

Currency: EUR2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-710.00K-858.00K-2.17M-4.55M-4.95M2.69M-7.16M-9.19M-8.06M-11.54M-8.04M
Investing Cash Flow-201.00K-117.00K-844.00K-723.00K-290.00K-332.00K-7.00K-197.00K-250.00K-61.00K-77.00K
Financing Cash Flow1.50M910.00K13.09M2.09M5.85M4.19M14.40M8.40M12.49M-1.84M5.21M
Capital Expenditure94.00K121.00K438.00K619.00K289.00K331.00K421.00K288.00K263.00K261.00K151.00K
Free Cash Flow-804.00K-979.00K-2.61M-5.17M-5.24M2.36M-7.58M-9.48M-8.30M-11.80M-8.19M
FCF to OCF113.24%114.10%120.17%113.62%105.84%87.71%105.88%103.13%103.07%102.26%101.88%

Earnings

Report DateAug 4, 2016May 16, 2017Sep 29, 2017Apr 3, 2018Sep 21, 2018Mar 8, 2019Aug 30, 2019Apr 21, 2020Jul 28, 2020Mar 17, 2021Sep 30, 2021Mar 15, 2022Sep 15, 2022Mar 15, 2023Mar 3, 2025Oct 13, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.00----0.000.00
EPS Actual-0.09-0.17-0.10-0.67-0.53-0.78-0.66-0.53-0.41-0.12-0.40-0.54-0.52-0.69-0.21-0.29
Surprise----------------
Timing-Pre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hours--

Key Statistics & Ratios

Market Cap22.61M
Enterprise Value23.03M
Trailing P/E0.00
Forward P/E0.00
Price / Sales24.98
Price / Book3.82
EPS-0.46
Book Value0.294
Revenue (TTM)905.00K
Gross Profit (TTM)-1.17M
EBITDA-9.20M
Profit Margin0.00%
Operating Margin-844.06%
Return on Equity-108.68%
Return on Assets-34.91%
Shares Outstanding35.49M
Shares Float22.95M
Beta-0.20
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jun 10, 2026181:178
  • Jun 10, 20251583:1573
  • Oct 14, 2019112:111